Pacira BioSciences, Inc.
Hedge Funds Holdings
Last updated:
Pacira BioSciences, Inc.‘s stocks are currently a part of 192 hedge funds’ portfolios, which represents 69.52% of the total amount of its stocks outstanding. This makes up a total of 32.28M shares of Pacira BioSciences, Inc.. Compared to the previous quarter, the number fell by -34.27% or -16.83M shares fewer. As for the holding position changes, 38.54% (74) of current hedge fund investors increased the number of shares held, 36.46% (70) of current holders sold a part of the shares held, and 15.63% (30) closed the holdings completely. 20 hedge funds are new holders of Pacira BioSciences, Inc. stock in Q2 2022, it is 10.42% of total holders.
Hedge funds holding Pacira BioSciences (Q3 2017 – Q2 2022)
| Q3 2017 | 178 |
|---|---|
| Q4 2017 | 181 |
| Q1 2018 | 167 |
| Q2 2018 | 154 |
| Q3 2018 | 186 |
| Q4 2018 | 206 |
| Q1 2019 | 208 |
| Q2 2019 | 218 |
| Q3 2019 | 211 |
| Q4 2019 | 228 |
| Q1 2020 | 222 |
| Q2 2020 | 245 |
| Q3 2020 | 253 |
| Q4 2020 | 256 |
| Q1 2021 | 265 |
| Q2 2021 | 252 |
| Q3 2021 | 249 |
| Q4 2021 | 264 |
| Q1 2022 | 289 |
| Q2 2022 | 192 |
Hedge funds changes in Pacira BioSciences positions (Q3 2017 – Q2 2022)
| Q3 2017 | 26 | 82 | 43 | 39 | -12 |
|---|---|---|---|---|---|
| Q4 2017 | 33 | 76 | 52 | 29 | -9 |
| Q1 2018 | 27 | 57 | 61 | 38 | -16 |
| Q2 2018 | 16 | 57 | 54 | 28 | -1 |
| Q3 2018 | 46 | 54 | 60 | 14 | 12 |
| Q4 2018 | 39 | 70 | 77 | 17 | 3 |
| Q1 2019 | 36 | 78 | 63 | 33 | -2 |
| Q2 2019 | 41 | 85 | 54 | 28 | 10 |
| Q3 2019 | 41 | 74 | 60 | 46 | -10 |
| Q4 2019 | 49 | 65 | 72 | 32 | 10 |
| Q1 2020 | 35 | 81 | 71 | 39 | -4 |
| Q2 2020 | 55 | 88 | 70 | 30 | 2 |
| Q3 2020 | 41 | 91 | 84 | 31 | 6 |
| Q4 2020 | 29 | 104 | 83 | 24 | 16 |
| Q1 2021 | 34 | 81 | 103 | 23 | 24 |
| Q2 2021 | 22 | 95 | 79 | 32 | 24 |
| Q3 2021 | 25 | 92 | 86 | 25 | 21 |
| Q4 2021 | 43 | 103 | 79 | 26 | 13 |
| Q1 2022 | 55 | 104 | 90 | 27 | 13 |
| Q2 2022 | 20 | 74 | 70 | 30 | -2 |
Hedge funds changes in Pacira BioSciences stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 46,711,000 | 16,237,000 |
|---|---|---|
| Q4 2017 | 26,692,000 | 14,763,000 |
| Q1 2018 | 12,009,000 | 27,947,000 |
| Q2 2018 | 12,187,000 | 27,638,000 |
| Q3 2018 | 42,487,000 | 44,438,000 |
| Q4 2018 | 31,313,000 | 7,812,000 |
| Q1 2019 | 9,454,000 | 5,231,000 |
| Q2 2019 | 9,614,000 | 7,848,000 |
| Q3 2019 | 6,542,000 | 4,054,000 |
| Q4 2019 | 5,713,000 | 2,567,000 |
| Q1 2020 | 8,825,000 | 11,469,000 |
| Q2 2020 | 6,889,000 | 9,590,000 |
| Q3 2020 | 2,949,000 | 7,130,000 |
| Q4 2020 | 10,139,000 | 8,964,000 |
| Q1 2021 | 9,917,000 | 4,450,000 |
| Q2 2021 | 6,134,000 | 3,087,000 |
| Q3 2021 | 6,094,000 | 2,087,000 |
| Q4 2021 | 1,667,000 | 5,083,000 |
| Q1 2022 | 2,755,000 | 26,857,000 |
| Q2 2022 | 343,000 | 84,000 |